Provisions governing hospital reimbursement for biological products to treat rare diseases modified.

Latest action: Introduction and first reading, referred to Health Finance and Policy

Voted 3/16/2026

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history